Search

Headquarters

Contact Us

  • (+01) 512 835 8026
  • info@myriadrbm.com
  • 3300 Duval Road
    Austin, TX 78759
    USA
  • Mon to Fri - 8:50am to 5:00pm

Ready to order?

Great! Every order starts with a quote.

Get Started

  • (+01) 512 835 8026
  • info@myriadrbm.com
Get a Quote Contact | FAQ's | Blog
Myriad RBM Myriad RBM

Innovative Biomarker Solutions

Toggle menu

Skip to content
  • About Us
    • About Myriad RBM

      Myriad RBM’s CLIA certified biomarker testing laboratory, is located in Austin, TX. Myriad RBM is a wholly owned subsidiary of Myriad Genetics, Inc. (MYGN), a leading molecular diagnostic company based in Salt Lake City, Utah which develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests.
    • About Myriad RBM

      • About Us
      • Management
      • Quality Policy
      • Employment
      • Partners
      • Sales Team
      • Certifications
    • Newsroom

      • Press
      • Company Newsletters
      • Conferences
      • Abstracts + Papers
      • Sign Up for Our Newsletter
      • Blog
    • Data Quality

      • Overview
      • Myriad RBM Technology
  • Biomarker Solutions
    • Solutions

      • Overview
      • Assay Change Log

      CustomMAP

      If a smaller, more focused panel of analytes is required, we can build a Custom MAP to meet your needs.

      Learn More »

      TruCulture Spike

    • Multiplexed Immunoassays

      • Full Biomarker Menu
      • DiscoveryMAP® v. 4.0
      • ExplorerMAP™ v. 1.0
      • HumanMAP® v. 2.0
      • CardiovascularMAP® v. 3.0
      • AngiogenesisMAP® v. 1.0
      • InflammationMAP® v. 1.1
      • ImmunoMAP® v. 1.0
      • NeuroMAP™ v. 1.0
      • MetabolicMAP® v. 1.0
      • KidneyMAP®
      • CytokineMAP A
      • CytokineMAP B
      • SARS-CoV-2/COVID-19 Research
      • Cytokine Storm Testing for SARS-CoV-2/COVID-19 Research
      • SARS-CoV-2 Multiplex Serology
      Webinar Registration
    • TruCulture

      Whole Blood Collection and Culture System

      Learn More »
      Quanterix simoa

      Ultrasensitive immunoassays manufactured by Myriad RBM and based on Quanterix’s Simoa technology.

      Learn More »
  • Resources + Support
    • Resources

      • Bibliography
      • White Papers
      • Application Notes
      • Events
      • Webinars
      • Blog
      • COVID-19/SARS-CoV-2 Research Tools
    • Support

      • Client Services
      • Request a Biomarker
      • Speak to a Scientist
  • How to Order
    • Ordering Information

      • How to Order
      • Request a quote
      • Acceptable Samples
      • Frequently Asked Questions
    • Request Information

      • Contact Client Services
      • Request a Biomarker
      • Speak to a Scientist
    • Ready to Order?

      Great!

      Every order starts with a quote.

      Get Started

  •  

Category Archives: Blog

8 Feb 2012

How soon do Alzheimer’s biomarkers start taking their toll?

February 8, 2012
Desiree Klingler-Gaston
Blog, Neuroscience and Neurological
Currently, hopes of preventing the worst of the decline seen with Alzheimer's disease lie in the early detection or identifying those who are predispo...
Read More
31 Jan 2012

Genetic Biomarkers for Colorectal Cancer

January 31, 2012
Desiree Klingler-Gaston
Blog, Cancer
A group of scientists have published new research on a panel of biomarkers, discovered using DNA microarrays and validated using qPCR, which can discr...
Read More
17 Jan 2012

Directionality to the Link between Inflammation and Depression

January 17, 2012
Desiree Klingler-Gaston
Blog, Inflammation
For quite some time researchers have known that depression and inflammation seem to be linked. What was less clear was whether inflammation throughout...
Read More
11 Jan 2012

Biomarkers Should Be Included in More Clinical Trials for Alzheimer’s

January 11, 2012
Desiree Klingler-Gaston
Blog, Neuroscience and Neurological
Last week, a panel of Alzheimer's disease researchers and thought leaders from the Alzheimer's Disease Biomarker Expert Working Group published their...
Read More
29 Dec 2011

Personalizing Cancer Treatment Using Biomarkers

December 29, 2011
Desiree Klingler-Gaston
Blog, Cancer
The ability of biomarkers to help predict response to treatment is one of their most powerful applications. New research on the response of breast can...
Read More
22 Dec 2011

Biomarker Strategies in drug development

December 22, 2011
Desiree Klingler-Gaston
Blog, Cancer
This article from the December issue of Nature Reviews Drug Discovery outlines the importance of a biomarker strategy for personalized medicine in onc...
Read More
6 Dec 2011

Early Detection of Parkinson’s Disease Using a Simple Blood Test?

December 6, 2011
Desiree Klingler-Gaston
Blog, Neuroscience and Neurological
Neurodegenerative diseases like Parkinson's are among the hardest to detect early and effectively treat. Clinical tests that allow doctors to diagnose...
Read More
1 … 16 17 18 19 20

Categories

  • Biomarkers (4)
  • Blog (135)
    • Autoimmune and Arthritis (10)
    • Cancer (28)
    • Cardiac (9)
    • Cytokines and Chemokines (20)
    • Diabetes (7)
    • Gastrointestinal (1)
    • Inflammation (42)
    • Neuroscience and Neurological (33)
    • News From the Lab (1)
    • Renal Function and Toxicity (8)
    • Technology- Multi-Analyte Profile (1)
    • TruCulture (2)
  • COVID-19 (2)
  • Press (38)
  • Utilized Myriad RBM's Services (43)

ABOUT MYRIAD RBM

Overview
Management
Quality Policy
Employment
Partners
Sales Team
Certifications

MAPs

Full Biomarker Menu
DiscoveryMAP® v. 3.3
ExplorerMAP™ v. 1.0
HumanMAP® v. 2.0
CardiovascularMAP® v. 3.0
AngiogenesisMAP® v. 1.0
InflammationMAP® v. 1.0
ImmunoMAP® v. 1.0
NeuroMAP™ v. 1.0
MetabolicMAP® v. 1.0
KidneyMAP®
CytokineMAP A
CytokineMAP B

RESOURCES

Bibliography
White Papers
Events
Webinars
Blog

SUPPORT

Customer Support
Speak to a Scientist
Assay Change Log
Request a Biomarker
FAQs

SOLUTIONS

Results Processing
Assay Development
Quality Control
Project Management

SERVICES

Multiplexed Assay Services
Ultrasensitive Assays
TruCulture

  • Jobs
  • Terms of Use
  • Privacy Practice
  • Analytes Listing
Copyright © 2021 Myriad RBM. All rights reserved. Myriad does not sell your personal information